E-ISSN 2636-834X
 

Original Research 


Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats

Gokhan Unal, Feyza Aricioglu.

Abstract
Objective: Schizophrenia is a devastating disorder with its positive (hallucination and delusion), negative (such as social withdrawal,
anhedonia), and cognitive (learning and attention deficits) symptoms. Although current antipsychotic drugs treat positive symptoms,
negative and cognitive symptoms have remained untreated. There is a limited number of studies showing the promising potential benefits of famotidine, an H2 receptor antagonist used for the treatment of peptic ulcer, in schizophrenic patients. In our previous study, it was showed that famotidine might improve schizophrenia-induced molecular deficits on Akt/GSK-3β/β-Catenin signaling pathway in SH-SY5Y cells and there is no translational study examining this effects of famotidine. Hence this study was designed to investigate the effects of famotidine on schizophrenia-like behavioral deficits in the acute ketamine model of schizophrenia in rats.
Methods: Male Sprague Dawley rats divided into the four groups as saline, famotidine, ketamine, ketamine+famotidine (n=8 per group). Prepulse inhibition (PPI) of acustic startle response, novel object recognition (NOR), fear conditioning (FC), and social interaction (SI) tests were performed to measure schizophrenia-like symptoms in rats. Ketamine (10 mg/kg) was administered 15 min before the PPI test or 15 mg/kg 30 min before the NOR, FC, and SI tests whereas famotidine (4.4 mg/kg) was administered 30 min before all behavioral tests.
Results: Ketamine decreased the PPI (%) at +8 dB (p<0.01) and +16 dB (p<0.001) prepulse intensities compared to saline and famotidine treated group had higher (p<0.05) PPI (%) at +16dB prepulse intensity compared to ketamine. In NOR test, ketamine injected rats did not cause an increase in time spent with novel objects compared to familiar ones. In contrast, saline and famotidine pretreated rats spent more (p<0.05 and p<0.01) time with a novel object than a familiar one. In FC, ketamine decreased the freezing time (p<0.05) compared to saline, while famotidine pretreatment found to be ineffective. In SI, ketamine caused a decrease in sniffing and total interaction compared to control, while famotidine pretreatment increased (p<0.05) the sniffing behavior compared to the ketamine group.
Conclusion: Our results indicated that beneficial effect of famotidine in previous clinical studies was confirmed in animal model of
schizophrenia in rats, and suggested translational value of this study for potential antipsychotic effects of famotidine.

Key words: Ketamine, Famotidine, Schizophrenia, Prepulse Inhibition, Novel Object Recognition


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Gokhan Unal
Articles by Feyza Aricioglu
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Unal G, Aricioglu F. Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. PBS. 2020; 10(2): 45-54. doi:10.5455/PBS.20200330095749


Web Style

Unal G, Aricioglu F. Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. http://www.pbsciences.org/?mno=95774 [Access: September 28, 2021]. doi:10.5455/PBS.20200330095749


AMA (American Medical Association) Style

Unal G, Aricioglu F. Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. PBS. 2020; 10(2): 45-54. doi:10.5455/PBS.20200330095749



Vancouver/ICMJE Style

Unal G, Aricioglu F. Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. PBS. (2020), [cited September 28, 2021]; 10(2): 45-54. doi:10.5455/PBS.20200330095749



Harvard Style

Unal, G. & Aricioglu, . F. (2020) Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. PBS, 10 (2), 45-54. doi:10.5455/PBS.20200330095749



Turabian Style

Unal, Gokhan, and Feyza Aricioglu. 2020. Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. Psychiatry and Behavioral Sciences, 10 (2), 45-54. doi:10.5455/PBS.20200330095749



Chicago Style

Unal, Gokhan, and Feyza Aricioglu. "Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats." Psychiatry and Behavioral Sciences 10 (2020), 45-54. doi:10.5455/PBS.20200330095749



MLA (The Modern Language Association) Style

Unal, Gokhan, and Feyza Aricioglu. "Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats." Psychiatry and Behavioral Sciences 10.2 (2020), 45-54. Print. doi:10.5455/PBS.20200330095749



APA (American Psychological Association) Style

Unal, G. & Aricioglu, . F. (2020) Famotidine Improved Schizophrenia-Like Behaviors in Acute Ketamine Model of Schizophrenia in Rats. Psychiatry and Behavioral Sciences, 10 (2), 45-54. doi:10.5455/PBS.20200330095749